|
|
||||||||
AJP - Cell Physiology, Vol 270, Issue 5 C1388-C1397, Copyright © 1996 by American Physiological Society
ARTICLES |
S. N. Orlov, J. Tremblay and P. Hamet
Centre de Recherche Hotel-Dieu de Montreal, Universite de Montreal, Quebec, Canada.
Vascular smooth muscle cells (VSMC) exhibit shrinkage-induced bumetanide-inhibited 86Rb influx and ethylisopropylamiloride (EIPA)-inhibited 22Na influx. In this study, we examined the role of these transport pathways in volume adjustment of VSMC after isosmotic and hyperosmotic shrinkage. Cell volume was assessed by measurement of [14C]urea distribution. An initial 18-20% cell volume decrease in isosmotically shrunken VSMC was followed by a regulatory volume increase (RVI). RVI was completely abolished by bumetanide but not by EIPA. No RVI was noted in hyperosmotically shrunken VSMC. The initial rate of bumetanide-inhibited 86Rb influx was two- to threefold higher in isosmotically shrunken VSMC than with hyperosmotic shrinkage. Hyperosmotic shrinkage of VSMC was accompanied by a three- to fourfold increase in the rate of bumetanide-inhibited 86Rb efflux, whereas isosmotic shrinkage augmented this component by only 20-30%. In contrast to bumetanide-inhibited 86Rb influx, isosmotic shrinkage slightly increased the rate of EIPA-sensitive 22Na influx. Hyperosmotic shrinkage led to transient activation of EIPA-inhibited 22Na influx, which was completely abolished in 15 min. Activation of adenosine 3',5'-cyclic monophosphate (cAMP) signaling with isoproterenol arborized VSMC and decreased their volume by approximately 15%. A similar volume decrease was seen in VSMC treated with the microfilament-disrupting compound, cytochalasin B. The isoproterenol-induced cell volume decrease was prolonged by the addition of bumetanide. Unlike isoproterenol, agents that raise intracellular Ca2+ (A-23187 and angiotensin II) did not modify VSMC volume. Thus our data demonstrate involvement of cAMP signaling in the regulating of VSMC volume and a key role of bumetanide-inhibited ion transport in the RVI after isosmotically induced shrinkage.
This article has been cited by other articles:
![]() |
G. Jiang, F. Akar, S. L. Cobbs, K. Lomashvilli, R. Lakkis, F. J. Gordon, R. L. Sutliff, and W. C. O'Neill Blood pressure regulates the activity and function of the Na-K-2Cl cotransporter in vascular smooth muscle Am J Physiol Heart Circ Physiol, April 1, 2004; 286(4): H1552 - H1557. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. M. Devlin, N. Solban, S. Tremblay, J. Gutkowska, W. Schurch, S. N. Orlov, R. Lewanczuk, P. Hamet, and J. Tremblay HCaRG is a novel regulator of renal epithelial cell growth and differentiation causing G2M arrest Am J Physiol Renal Physiol, April 1, 2003; 284(4): F753 - F762. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. R. Gosmanov, E. G. Schneider, and D. B. Thomason NKCC activity restores muscle water during hyperosmotic challenge independent of insulin, ERK, and p38 MAPK Am J Physiol Regulatory Integrative Comp Physiol, March 1, 2003; 284(3): R655 - R665. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. N. Orlov, S. Taurin, N. Thorin-Trescases, N. O. Dulin, J. Tremblay, and P. Hamet Inversion of the Intracellular Na+/K+ Ratio Blocks Apoptosis in Vascular Smooth Muscle Cells by Induction of RNA Synthesis Hypertension, May 1, 2000; 35(5): 1062 - 1068. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M. Russell Sodium-Potassium-Chloride Cotransport Physiol Rev, January 1, 2000; 80(1): 211 - 276. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Akar, E. Skinner, J. D. Klein, M. Jena, R. J. Paul, and W. C. O'Neill Vasoconstrictors and nitrovasodilators reciprocally regulate the Na+-K+-2Cl- cotransporter in rat aorta Am J Physiol Cell Physiol, June 1, 1999; 276(6): C1383 - C1390. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. C. O'Neill Physiological significance of volume-regulatory transporters Am J Physiol Cell Physiol, May 1, 1999; 276(5): C995 - C1011. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. N. Orlov, N. C. Adragna, V. A. Adarichev, and P. Hamet Genetic and biochemical determinants of abnormal monovalent ion transport in primary hypertension Am J Physiol Cell Physiol, March 1, 1999; 276(3): C511 - C536. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |